Transient newborn neutropenia immediately after chemotherapy during pregnancy: A case report / 대한산부인과학회지
Korean Journal of Obstetrics and Gynecology
; : 833-837, 2010.
Article
en Ko
| WPRIM
| ID: wpr-28754
Biblioteca responsable:
WPRO
ABSTRACT
The incidence of acute leukemia in pregnancy is as low as 1 in 75,000 pregnancies. There is no established guideline for the treatment of leukemia during midtrimester pregnancy. But nowadays, consensus is not to delay the leukemia treatment with chemotherapy even in pregnancy. Many authors reported successful outcomes of mothers and newborns. Because of the leukemia itself and side effects of the chemotherapy, anemia, thrombocytopenia and neutropenia are commonly encountered in women treated with chemotherapy. With chemotherapy in utero just before the delivery, the newborn could be neutopenic. We report one case of midtrimester pregnant woman who took chemotherapy for leukemia and suffered from neutropenic fever and preterm labor. The newborn was neutropenic. However, both the mother and the baby were successfully recovered from neutropenia.
Palabras clave
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Segundo Trimestre del Embarazo
/
Trombocitopenia
/
Leucemia
/
Incidencia
/
Consenso
/
Mujeres Embarazadas
/
Fiebre
/
Anemia
/
Trabajo de Parto Prematuro
/
Madres
Tipo de estudio:
Guideline
/
Incidence_studies
/
Prognostic_studies
Límite:
Female
/
Humans
/
Newborn
/
Pregnancy
Idioma:
Ko
Revista:
Korean Journal of Obstetrics and Gynecology
Año:
2010
Tipo del documento:
Article